Earnings History Data for NanoViricides, Inc. (NNVC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NanoViricides, Inc.

NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development of drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides, Inc. is headquartered in West Haven, Connecticut.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
15-11-2021 PM NNVC NanoViricides, Inc. 53.20 -0.23 0.00 -0.22 NanoViricides reports Q3 results
[11/16/2021 7:20 AM]
4.76 0.01 
4.81 0.06 
2.85 - 8.71 221,721 230,000 12,631
16-02-2021 ?? NNVC NanoViricides, Inc. 58.55 -0.22 0.00 -0.50 NanoViricides reports FQ2 results
[2/17/2021 6:28 AM]
4.64 -0.30 
4.97 0.02 
2.85 - 12.90 179,026 495,893 3,234